Trial
NCT03621605
A Phase1 Study of VIB9600
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
CTI Clinical Trial and Consulting Services
Condition
Safety Issues
Intervention
VIB9600
Why stopped
Study terminated due to tolerability issues.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-13